Form 4: Health In Tech Director Grants Power of Attorney
Power of Attorney
Health In Tech, Inc. director Timothy Hayes has executed a Power of Attorney, authorizing specific individuals to manage SEC filings related to his securities ownership and transactions.
Summary
- Timothy Hayes, a director of Health In Tech, Inc., has formally granted a Power of Attorney (POA) to Julia (LinLin) Qian, Kristy Li, and Lori Babcock.
- This POA authorizes these individuals to act on his behalf for all SEC filings, including Forms 3, 4, and 5, which pertain to beneficial ownership, acquisitions, and dispositions of company securities.
- The appointed attorneys-in-fact can also request electronic filing codes from the SEC, prepare and file Form 144 for proposed securities sales under Rule 144, and perform any other necessary actions related to these filings.
- The POA clarifies that the attorneys-in-fact and the Company are not assuming the undersigned's compliance responsibilities or liabilities under the Securities Act or Section 16(a) of the Exchange Act, nor any liability for profit disgorgement under Section 16(b).
- The Power of Attorney is effective until Mr. Hayes is no longer required to file these specific forms and revokes any prior POAs for company securities, while not revoking other previously granted POAs.
- The document was executed on July 10, 2026, with the earliest transaction date noted in a related filing being July 8, 2026.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it pertains to administrative procedural matters (delegation of authority for SEC filings) rather than operational or financial performance.
Positives
- Clear delegation of responsibilities for SEC filings ensures compliance with reporting requirements.
- Proactive measure to manage ownership and transaction reporting, indicating a commitment to transparency.
- The POA is comprehensive, covering various forms and actions necessary for securities reporting.
Negatives
- The filing itself does not contain financial performance data, making it impossible to assess the company's operational health.
- The POA explicitly disclaims assumption of liability by the attorneys-in-fact or the company for the director's compliance failures or Section 16(b) violations.
Risks
- Potential for errors or omissions in filings if the appointed attorneys-in-fact are not diligent, although the POA aims to mitigate this.
- The disclaimer of liability for Section 16(b) violations highlights the inherent risks associated with insider trading regulations.
- Reliance on third parties for critical compliance tasks introduces a dependency risk.
Future Outlook
The filing does not contain forward-looking statements or guidance regarding the company's financial performance or strategic direction.
Management Comments
- The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, (i) any of the undersigneds responsibilities to comply with the Securities Act or Section 16(a) of the Exchange Act or any liability for the undersigneds failure to comply with such requirements or (ii) any obligation or liability that the undersigned incurs for profit disgorgement under Section 16(b) of the Exchange Act.
- The Company will use all reasonable efforts to apprise the undersigned of applicable filing requirements for purposes of the Securities Act or Section 16(a) of the Exchange Act.
Industry Context
StockSavvy.ai notes that the execution of a Power of Attorney for SEC filings is a common practice for corporate insiders, particularly directors and officers, to ensure timely and accurate reporting of their securities transactions and holdings as mandated by regulations like Section 16 of the Exchange Act. This practice is standard across the publicly traded company landscape.
Stakeholder Impact
- Shareholders: Ensures continued compliance with reporting requirements, contributing to market transparency.
- Management/Board: Facilitates efficient handling of insider reporting obligations for directors.
- Regulatory Bodies (SEC): Supports the SEC's oversight by ensuring timely and accurate filing of ownership information.
Next Steps
- The appointed attorneys-in-fact will manage and file all required Forms 3, 4, and 5, and Form 144 on behalf of Timothy Hayes.
- The Company will continue to provide reasonable efforts to inform Mr. Hayes of applicable filing requirements.
Key Dates
| Date | Description |
|---|---|
| 07/08/2026 | Earliest transaction date noted in related Form 4 filing. |
| 07/10/2026 | Date of execution for the Power of Attorney. |
Keywords
Power of Attorney, SEC Filings, Form 3, Form 4, Form 5, Form 144, Securities Exchange Act of 1934, Section 16(a), Section 16(b), Rule 144, Beneficial Ownership, Insider Trading, Health In Tech, Inc., Director Filings, Securities Act of 1933
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.